FibroBiologics Inc. (NASDAQ: FBLG) Stock Information | RedChip

FibroBiologics Inc. (NASDAQ: FBLG)


$5.32
+0.3150 ( +6.30% ) 132.5K

FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal.

Market Data


Open


$5.32

Previous close


$5.00

Volume


132.5K

Market cap


$189.67M

Day range


$4.93 - $5.42

52 week range


$3.90 - $55.00

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 16 Feb 06, 2024
8-k 8K-related 16 Feb 02, 2024

Latest News